Related references
Note: Only part of the references are listed.Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer
Chunlai Feng et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
In the triple-negative breast cancer MDA-MB-231 cell line, sulforaphane enhances the intracellular accumulation and anticancer action of doxorubicin encapsulated in liposomes
Lidia Mielczarek et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Cerasomal Lovastatin Nanohybrids for Efficient Inhibition of Triple-Negative Breast Cancer Stem Cells To Improve Therapeutic Efficacy
Liujiang Song et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells
Yaqi Lv et al.
ACS NANO (2018)
Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
Alice Lee et al.
CANCER TREATMENT REVIEWS (2018)
Loading Lovastatin into Camptothecin-Floxuridine Conjugate Nanocapsules for Enhancing Anti-metastatic Efficacy of Cocktail Chemotherapy on Triple-negative Breast Cancer
Nisi Zhang et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression
Shashi Kumar Gupta et al.
CIRCULATION RESEARCH (2018)
Investigation of different types of nano drug delivery systems of atorvastatin for the treatment of hyperlipidemia
Mahima Mathur et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2018)
Amphiphilic Drug Conjugates as Nanomedicines for Combined Cancer Therapy
Chuang Gao et al.
BIOCONJUGATE CHEMISTRY (2018)
Rhinacanthin-C enhances doxorubicin cytotoxicity via inhibiting the functions of P-glycoprotein and MRP2 in breast cancer cells
Tassarut Chaisit et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Nano-sized solid dispersions based on hydrophobic-hydrophilic conjugates for dissolution enhancement of poorly water-soluble drugs
Ha T. T. Dinh et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Synergistic chemotherapeutic effect of sorafenib-loaded pullulan-Dox conjugate nanoparticles against murine breast carcinoma
Junhui Sui et al.
NANOSCALE (2017)
Methotrexate-Camptothecin Prodrug Nanoassemblies as a Versatile Nanoplatform for Biomodal Imaging-Guided Self-Active Targeted and Synergistic Chemotherapy
Yang Li et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Effects of Particle Hydrophobicity, Surface Charge, Media pH Value and Complexation with Human Serum Albumin on Drug Release Behavior of Mitoxantrone-Loaded Pullulan Nanoparticles
Xiaojun Tao et al.
NANOMATERIALS (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Effects of Lovastatin on MDA-MB-231 Breast Cancer Cells: An Antibody Microarray Analysis
Tao Yang et al.
JOURNAL OF CANCER (2016)
Cholesterol-Modified Amino-Pullulan Nanoparticles as a Drug Carrier: Comparative Study of Cholesterol-Modified Carboxyethyl Pullulan and Pullulan Nanoparticles
Xiaojun Tao et al.
NANOMATERIALS (2016)
Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment
Liqiong Cai et al.
BIOMATERIALS (2015)
Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a
Adam R. Wolfe et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy
Bo Xiao et al.
JOURNAL OF MATERIALS CHEMISTRY B (2015)
Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer
Takeo Fujii et al.
JAMA ONCOLOGY (2015)
Co-delivery of Cisplatin and Rapamycin for Enhanced Anticancer Therapy through Synergistic Effects and Microenvironment Modulation
Shutao Guo et al.
ACS NANO (2014)
Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer
Lei Miao et al.
ADVANCED FUNCTIONAL MATERIALS (2014)
pH-Sensitive nano-systems for drug delivery in cancer therapy
Juan Liu et al.
BIOTECHNOLOGY ADVANCES (2014)
Synthesis and self-assembly of a mikto-arm star dual drug amphiphile containing both paclitaxel and camptothecin
A. G. Cheetham et al.
JOURNAL OF MATERIALS CHEMISTRY B (2014)
Smart pH-Sensitive and Temporal-Controlled Polymeric Micelles for Effective Combination Therapy of Doxorubicin and Disulfiram
Xiaopin Duan et al.
ACS NANO (2013)
Revisiting the Isobole and Related Quantitative Methods for Assessing Drug Synergism
Ronald J. Tallarida
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy Preface
Hiroshi Maeda et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Tumor delivery of macromolecular drugs based on the EPR effect
Vladimir Torchilin
ADVANCED DRUG DELIVERY REVIEWS (2011)
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Sarbari Acharya et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance
Li Fan et al.
BIOMATERIALS (2010)
Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance
Anna Martirosyan et al.
BMC CANCER (2010)
Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents
Carolyn A. Goard et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Combinatorial Drug Conjugation Enables Nanoparticle Dual-Drug Delivery
Santosh Aryal et al.
SMALL (2010)
Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers
Sharon Nofech-Mozes et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Coadministration of Paclitaxel and Curcumin in Nanoemulsion Formulations To Overcome Multidrug Resistance in Tumor Cells
Srinivas Ganta et al.
MOLECULAR PHARMACEUTICS (2009)
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Joseph Lehar et al.
NATURE BIOTECHNOLOGY (2009)
Breast cancer growth prevention by statins
Michael J. Campbell et al.
CANCER RESEARCH (2006)
Lovastatin and beyond: The history of the HMG-CoA reductase inhibitors
JA Tobert
NATURE REVIEWS DRUG DISCOVERY (2003)
Interaction of cytosine arabinoside and lovastatin in human leukemia cells
SA Holstein et al.
LEUKEMIA RESEARCH (2001)
HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein
EJ Wang et al.
PHARMACEUTICAL RESEARCH (2001)
Share Paper
